34D Stock Chart & Stats
€60.72
€1.30(1.28%)
At close: 4:00 PM EST
€60.72
€1.30(1.28%)
Day’s Range― - ―
52-Week Range€55.26 - €90.76
Previous CloseN/A
Volume0.00
Average Volume (3M)16.00
Market Cap
€3.61B
Enterprise Value€4.62K
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€711.00M
Price to Earnings (P/E)25.8
Beta0.47
Next Earnings
Jul 31, 2026EPS Estimate
0.98Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.59
Shares Outstanding55,948,257
10 Day Avg. Volume30
30 Day Avg. Volume16
Financial Highlights & Ratios
PEG Ratio-1.37
Price to Book (P/B)2.42
Price to Sales (P/S)3.21
P/FCF Ratio18.72
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€66.88Price Target Upside10.15% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)3.95
Revenue Forecast (FY)€1.23B
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDiaSorin reported 4Q results which were a slight beat vs Consensus on Topline and EBITDA, starting the year on a solid footing backdrop considered.
Growth OutlookManagement also pointed to ~25% combined yoy growth for the Verigene and LIAISON PLEX to around €75m, which implies low-teens growth for FY25 in Molecular Diagnostics for FY25, which serves as a solid departure point into FY25.
Bears Say
Market SurprisesThe headline of a lower Molecular Diagnostic 4Q into a strong respiratory season took us by surprise.
Regional Growth DisparityEuropean growth slowed to 4% CER, with US growing 15%, effectively normalising above average growth driven by high market share tests.
DiaSorin S.p.A. News
34D FAQ
What was DiaSorin S.p.A.’s price range in the past 12 months?
DiaSorin S.p.A. lowest stock price was €55.26 and its highest was €90.76 in the past 12 months.
What is DiaSorin S.p.A.’s market cap?
DiaSorin S.p.A.’s market cap is €3.61B.
When is DiaSorin S.p.A.’s upcoming earnings report date?
DiaSorin S.p.A.’s upcoming earnings report date is Jul 31, 2026 which is in 6 days.
How were DiaSorin S.p.A.’s earnings last quarter?
DiaSorin S.p.A. released its earnings results on May 07, 2026. The company reported €0.91 earnings per share for the quarter, beating the consensus estimate of €0.845 by €0.065.
Is DiaSorin S.p.A. overvalued?
According to Wall Street analysts DiaSorin S.p.A.’s price is currently Undervalued.
Does DiaSorin S.p.A. pay dividends?
DiaSorin S.p.A. does not currently pay dividends.
What is DiaSorin S.p.A.’s EPS estimate?
DiaSorin S.p.A.’s EPS estimate is 0.98.
How many shares outstanding does DiaSorin S.p.A. have?
DiaSorin S.p.A. has 55,948,257 shares outstanding.
What happened to DiaSorin S.p.A.’s price movement after its last earnings report?
DiaSorin S.p.A. reported an EPS of €0.91 in its last earnings report, beating expectations of €0.845. Following the earnings report the stock price went up 1.828%.
Which hedge fund is a major shareholder of DiaSorin S.p.A.?
Currently, no hedge funds are holding shares in DE:34D
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DiaSorin S.p.A.
DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
34D Stock 12 Month Forecast
Average Price Target
€66.88
▲(10.15% Upside)
Technical Analysis
Amplifon S.p.A.
―
El.En. S.p.A.
―
Fidia Spa
―
Recordati Industria Chimica e Farmaceutica SPA
―
Safilo Group SpA
―